Table 5.
Risk Factors for the Development of Metachronous Cancer
| Variable | HR | 95% CI | p-value |
|---|---|---|---|
| Age (each incremental year) | 1.059 | 1.001–1.120 | 0.045 |
| Male (female-reference) | 2.827 | 0.654–12.216 | 0.164 |
| Antral mucosal atrophy (each incremental grade) | 1.578 | 0.920–2.706 | 0.098 |
| Corpus mucosal atrophy (each incremental grade) | 0.790 | 0.469–1.330 | 0.375 |
| Antral intestinal metaplasia (each incremental grade) | 0.743 | 0.440–1.254 | 0.267 |
| Corpus intestinal metaplasia (each incremental grade) | 1.453 | 0.915–2.308 | 0.113 |
| Negative group (persistent group-reference) | 1.583 | 0.629–3.985 | 0.330 |
| Eradicated group (persistent group-reference) | 0.862 | 0.309–2.402 | 0.776 |
HR, hazard ratio; CI, confidence interval.